Analytic Tool Aiding Clinical Studies of Ganetespib for Advanced Ovarian Cancers

Analytic Tool Aiding Clinical Studies of Ganetespib for Advanced Ovarian Cancers
Parsortix, a system developed by Angle Plc. to harvest circulating tumor cells in the blood of cancer patients, has been used as part of the GANNET 53 project testing the efficacy of the drug Ganetespib for the treatment of ovarian cancer.

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.

Leave a Comment

Your email address will not be published. Required fields are marked *